BIOCRYST PHARMACEUTICALS INC (BCRX) Institutional Ownership Changes & 13F Activity

BIOCRYST PHARMACEUTICALS INC (BCRX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Royalty Pharma Sub-Manager, Llc, Millennium Management Llc, Kynam Capital Management, Lp, Perceptive Advisors Llc, and Jane Street Group, Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Manufacturers Life Insurance Company, TheBuy+17,474+17.1%119,516$1.20MQ2 2026Sep 09, 2026
Integrated Wealth Concepts LlcBuy+10,77810,778$107.78KQ2 2026Sep 09, 2026
Citadel Advisors LlcBuy+740,417+72.7%1,759,160$17.59MQ2 2026Sep 02, 2026
Corient Private Wealth LlcBuy+54,980+57.6%150,447$1.50MQ2 2026Aug 27, 2026
California State Teachers Retirement SystemSell-7,115-2.8%251,230$2.51MQ2 2026Aug 24, 2026
Royalty Pharma Sub-Manager, LlcSell-3,846,154-100.0%0$0.00Q2 2026Aug 21, 2026
Assenagon Asset Management S.A.Buy+120,097+51.6%353,044$3.53MQ2 2026Aug 21, 2026
Nantahala Capital Management, LlcSell-86,237-4.3%1,901,160$19.01MQ2 2026Aug 19, 2026
Mercer Global Advisors IncBuy+51,453+513.6%61,472$614.72KQ2 2026Aug 19, 2026
Seven Fleet Capital Management LpSell-51,469-50.2%51,024$510.24KQ2 2026Aug 17, 2026
Millennium Management LlcBuy+3,207,008+1708.4%3,394,729$33.95MQ2 2026Aug 14, 2026
Kynam Capital Management, LpSell-3,158,135-55.6%2,522,660$25.23MQ2 2026Aug 14, 2026
Perceptive Advisors LlcBuy+2,874,855+38.7%10,308,888$103.09MQ2 2026Aug 14, 2026
Jane Street Group, LlcBuy+2,140,076+343.7%2,762,683$27.63MQ2 2026Aug 14, 2026
Goldman Sachs Group IncBuy+2,134,431+90.9%4,481,874$44.82MQ2 2026Aug 14, 2026
Aqr Capital Management LlcBuy+1,774,161+403.1%2,214,302$22.14MQ2 2026Aug 14, 2026
Susquehanna International Group, LlpSell-1,619,653-57.5%1,195,651$11.96MQ2 2026Aug 14, 2026
Vestal Point Capital, LpBuy+1,275,000+18.1%8,300,000$83.00MQ2 2026Aug 14, 2026
Invesco Ltd.Buy+1,233,7831,233,783$12.34MQ2 2026Aug 14, 2026
Eversept Partners, LpSell-1,174,167-38.6%1,865,653$18.66MQ2 2026Aug 14, 2026
Hrt Financial LpBuy+1,081,5231,081,523$10.81MQ2 2026Aug 14, 2026
Moore Capital Management, LpBuy+848,336848,336$8.48MQ2 2026Aug 14, 2026
Schonfeld Strategic Advisors LlcSell-626,877-46.9%710,816$7.11MQ2 2026Aug 14, 2026
Man Group PlcSell-560,433-43.3%732,867$7.33MQ2 2026Aug 14, 2026
Exoduspoint Capital Management, LpBuy+554,859+291.9%744,917$7.45MQ2 2026Aug 14, 2026
Pdt Partners, LlcSell-538,951-95.7%24,489$244.89KQ2 2026Aug 14, 2026
Elmind Capital, LpSell-480,000-48.0%520,000$5.20MQ2 2026Aug 14, 2026
Sphera Funds Management Ltd.Sell-444,413-51.3%422,051$4.22MQ2 2026Aug 14, 2026
Orbimed Advisors LlcBuy+426,800+29.9%1,852,000$18.52MQ2 2026Aug 14, 2026
Two Sigma Investments, LpBuy+382,721+6.0%6,775,349$67.75MQ2 2026Aug 14, 2026
Showing 30 of 306

Frequently asked questions about BCRX activity

  • Which institutional owners are buying BCRX?

    Institutional owners buying BCRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in BCRX activity?

    "Buy" means an investor increased their reported position in BCRX compared to the prior reporting period. This reflects growing exposure to BIOCRYST PHARMACEUTICALS INC (BCRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in BCRX increasing?

    Institutional interest in BCRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.